Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Minority Interest: 2022-2025

Historic Minority Interest for P3 Health Partners (PIII) over the last 4 years, with Q3 2025 value amounting to $37.6 million.

  • P3 Health Partners' Minority Interest fell 7376.93% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year decrease of 7376.93%. This contributed to the annual value of $73.6 million for FY2024, which is 7475.65% down from last year.
  • As of Q3 2025, P3 Health Partners' Minority Interest stood at $37.6 million, which was down 7376.93% from $42.7 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Minority Interest ranged from a high of $1.8 billion in Q1 2022 and a low of $37.6 million during Q3 2025
  • In the last 4 years, P3 Health Partners' Minority Interest had a median value of $291.5 million in 2023 and averaged $452.5 million.
  • Per our database at Business Quant, P3 Health Partners' Minority Interest crashed by 3374.53% in 2023 and then tumbled by 7842.33% in 2025.
  • P3 Health Partners' Minority Interest (Quarter) stood at $516.8 million in 2022, then tumbled by 43.59% to $291.5 million in 2023, then crashed by 74.76% to $73.6 million in 2024, then tumbled by 48.89% to $37.6 million in 2025.
  • Its Minority Interest stands at $37.6 million for Q3 2025, versus $42.7 million for Q2 2025 and $57.8 million for Q1 2025.